To validate the influence of cancer stemness associated genes on immunotherapy effectiveness, a previously published scRNA-seq dataset of PD1 ICI-treated patients with melanoma (SKCM) was initially employed to investigate the correlation between cancer stemness and ICI responses. The gene discussed is PDCD1; the disease is melanoma.